Shu-Fen Chiang Selected Research

Shu-Fen Chiang Research Topics

Disease

22	Neoplasms (Cancer) 07/2022 - 04/2008
8	Rectal Neoplasms (Rectal Cancer) 07/2022 - 01/2018
8	Neoplasm Metastasis (Metastasis) 01/2022 - 09/2013
4	Colorectal Neoplasms (Colorectal Cancer) 07/2022 - 01/2018
3	Adenocarcinoma of Lung 01/2021 - 04/2010
3	Breast Neoplasms (Breast Cancer) 01/2019 - 04/2008
2	Adenocarcinoma 07/2022 - 03/2006
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2018 - 10/2004
2	Lymphoma (Lymphomas) 04/2018 - 10/2010
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2018 - 01/2018
1	Bites and Stings (Sting) 07/2022
1	Turcot syndrome 12/2021
1	Microsatellite Instability 12/2021
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 10/2021
1	Carcinoma (Carcinomatosis) 12/2020
1	Lymphatic Metastasis 02/2019
1	Triple Negative Breast Neoplasms 04/2018
1	Ovarian Neoplasms (Ovarian Cancer) 04/2018
1	Hypertension (High Blood Pressure) 01/2018
1	Heart Failure 01/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2017
1	Pharyngeal Neoplasms 09/2017
1	Cardiotoxicity 11/2016
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 10/2013
1	Glioblastoma (Glioblastoma Multiforme) 10/2013
1	Ataxia Telangiectasia (Louis Bar Syndrome) 10/2013
1	Amelanotic Melanoma (Amelanotic Melanomas) 04/2013
1	Disease Progression 08/2011
1	Hypoxia (Hypoxemia) 10/2010
1	Lung Neoplasms (Lung Cancer) 03/2006
1	Latent Infection 04/2005

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 12/2021 - 09/2017
5	Immune Checkpoint InhibitorsIBA 07/2022 - 02/2019
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2010
4	LigandsIBA 12/2020 - 10/2010
3	B7-H1 AntigenIBA 01/2022 - 10/2018
2	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 10/2021 - 01/2021
2	CytokinesIBA 01/2021 - 10/2010
2	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2021 - 10/2013
2	ErbB Receptors (EGF Receptor)IBA 01/2019 - 12/2018
2	Small Interfering RNA (siRNA)IBA 04/2018 - 09/2013
2	HMGB1 Protein (HMG1)IBA 04/2018 - 01/2018
2	Antineoplastic Agents (Antineoplastics)IBA 01/2018 - 11/2016
2	Biological ProductsIBA 09/2017 - 08/2011
2	Adenosine Triphosphatases (ATPase)IBA 10/2013 - 04/2010
2	RNA (Ribonucleic Acid)IBA 04/2013 - 04/2005
1	Interferon Type IIBA 07/2022
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 12/2021
1	Pattern Recognition ReceptorsIBA 10/2021
1	Ligases (Synthetase)IBA 01/2021
1	Endoplasmic Reticulum Chaperone BiPIBA 01/2021
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 02/2020
1	Decitabine FDA Link 02/2020
1	MethyltransferasesIBA 02/2020
1	Tyrosine Kinase InhibitorsIBA 12/2018
1	Deubiquitinating EnzymesIBA 04/2018
1	Histone MethyltransferasesIBA 04/2018
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 01/2018
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2018
1	Dynamins (Dynamin)IBA 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2017
1	Somatomedin Receptors (Somatomedin Receptor)IBA 11/2016
1	Heat Shock Transcription FactorsIBA 11/2016
1	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2016
1	Phosphotransferases (Kinase)IBA 10/2013
1	Histones (Histone)IBA 10/2013
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2013
1	trans-1,2-dihydrobenzene-1,2-diol dehydrogenase (dihydrodiol dehydrogenase)IBA 09/2013
1	Oncogene Proteins (Oncogene Protein)IBA 04/2013
1	Apoptosis Regulatory ProteinsIBA 04/2013
1	Peptide Elongation Factor 2 (EF-2)IBA 08/2011
1	Insulin-Like Growth Factor Binding Protein 3IBA 10/2010
1	SARS-CoV spike glycoproteinIBA 10/2010
1	Fluorouracil (Carac)FDA LinkGeneric 04/2008
1	Thymidylate SynthaseIBA 04/2008
1	Nicotine FDA Link 03/2006
1	Proto-Oncogene Proteins c-metIBA 03/2006
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 03/2006
1	Matrix Metalloproteinases (MMPs)IBA 10/2004

Therapy/Procedure

7	Neoadjuvant Therapy 10/2021 - 01/2018
6	Drug Therapy (Chemotherapy) 07/2022 - 04/2008
4	Radiotherapy 07/2022 - 10/2013
4	Therapeutics 07/2022 - 11/2016
2	Adjuvant Chemotherapy 07/2022 - 01/2021
2	Chemoradiotherapy 10/2021 - 01/2021
2	Precision Medicine 01/2021 - 05/2020
1	Immunotherapy 02/2020